Twist Bioscience (TWST) Raw Materials (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Raw Materials data on file, last reported at $25.5 million in Q1 2026.

• Raw Materials for Q1 2026 came in at $25.5 million, up 78.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.5 million (up 78.74% YoY), and the FY2025 annual result was $20.2 million, up 16.6% from the prior year.
• Raw Materials rose to $25.5 million in Q1 2026 per TWST's latest filing, from $24.7 million in the prior quarter.
• Over five years, Raw Materials peaked at $33.6 million in Q1 2023 and troughed at $14.3 million in Q1 2025.
• A 5-year average of $24.7 million and a median of $24.7 million in 2025 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2022 and 2024: Raw Materials soared 180.8% in 2022, then tumbled 35.92% in 2024.
• A 5-year view of Raw Materials shows it stood at $33.6 million in 2022, then decreased by 29.22% to $23.8 million in 2023, then sank by 32.51% to $16.0 million in 2024, then soared by 53.86% to $24.7 million in 2025, then increased by 3.58% to $25.5 million in 2026.
• Business Quant data shows TWST's Raw Materials at $25.5 million in Q1 2026, $24.7 million in Q4 2025, and $20.2 million in Q3 2025.